Monsanto (MON +1.3%) is upgraded to Buy with a new $100 target price at Monness Crespi, as...


Monsanto (MON +1.3%) is upgraded to Buy with a new $100 target price at Monness Crespi, as continually increasing glyphosate prices are leading to greater EPS upside in 2013. The firm sees MON benefiting from these higher prices, both in its branded Roundup products as well as in its generic glyphosate, and raises estimates to well above consensus.

From other sites
Comments (1)
  • Michael Bryant
    , contributor
    Comments (6944) | Send Message
     
    And India banned GMO products. Who's next.
    5 Nov 2012, 05:51 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs